InnovAge Holding Corp. (INNV)

NASDAQ: INNV · USD

$9.13

+0.01 (+0.1%)· Recorded snapshot

Market cap	1.2B
Revenue (ttm)	989.7M
Net income (ttm)	-2.5M
EPS (ttm)	-$0.02
Shares out	136.5M
P/E (forward)	20.8x
Volume	402,999
Beta	0.15

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 989.7M
Net income (ttm): -2.5M
EPS (ttm): -$0.02
P/E (forward): 20.8x
Market cap: 1.2B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	ถือ

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E20.8

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-0.3

P25 n/aP50 n/aP75 n/a

ROIC-6.9

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All INNV indicators

Market & fundamental data

Available fields

241

Groups with data

Currency

USD

Showing 241 of 241 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001834376
Company name	InnovAge Holding Corp.
Country	United States
Country code	US
CUSIP number	45784A104
Earnings date	2026-11-03
Earnings time	amc
Employees	2,500
Employees change	60
Employees growth	2.46%
Enterprise value	$1.2B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	June
Founded	2007
In index	RUSSELL2000
Industry	Medical Care Facilities
IPO date	2021-03-04
Is primary listing	Yes
Is SPAC	No
ISIN number	US45784A1043
Last 10-K release date	2026-09-09
Last earnings date	2026-09-08
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$1.2B
Market cap category	Small-Cap
Next earnings date	2026-11-03
Options	Yes
Price	$9.13
Price currency	USD
Sector	Healthcare
SIC code	8000
Stock price date	2026-10-28
Symbol	INNV
U.S. state	Colorado
Website	https://www.innovage.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	20.56x
Earnings yield	-0.22%
EV/EBIT	206.18x
EV/EBITDA	44.22x
EV/FCF	23.61x
EV/Sales	1.2x
FCF / EV yield	4.24%
FCF yield	4.05%
Forward EV/Sales	1.11x
Forward P/E	20.76x
Forward P/S	1.16x
Industry forward P/E	14.81x
Industry P/E	18.21x
P/(FCF - SBC) ratio	28.7x
P/(OCF - SBC) ratio	21.58x
P/B ratio	5.27x
P/FCF ratio	24.69x
P/OCF ratio	19.23x
P/S ratio	1.26x
Price / tangible book value	13.78x
Price/EBITDA ratio	46.24x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	0.58%
EBITDA margin	2.72%
Effective tax rate	356.77%
FCF margin	5.09%
Gross margin	68.47%
Operating margin	0.58%
Pretax margin	0.03%
Profit margin	-0.26%
Profit per employee	$-1,015
Profitable quarters	1
Revenue per employee	$395,883
ROA	0.67%
ROA (5Y)	-1.63%
ROCE	1.63%
ROE	-0.26%
ROE (5Y)	-7.13%
ROIC	-6.92%
ROIC (5Y)	-7.28%
SBC / revenue	0.71%
Tax / revenue	0.1%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	1
FCF growth	89.47%
FCF growth (Q)	85.44%
FCF growth (QoQ)	17.1%
Gross profit growth	15.87%
Gross profit growth (Q)	19.3%
Gross profit growth 3Y	12.51%
Gross profit growth 5Y	6.99%
Net income growth quarters	1
Net income growth years	1
OCF growth	96.9%
OCF growth (Q)	136.52%
OCF growth (QoQ)	17.36%
OCF growth 3Y	47.33%
Operating income growth (Q)	0.96%
Operating income growth 5Y	-38.52%
Revenue growth	15.93%
Revenue growth (Q)	18.31%
Revenue growth (QoQ)	3.97%
Revenue growth 3Y	12.88%
Revenue growth 5Y	9.19%
Revenue growth quarters	13
Revenue growth years	3

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-14.3M
Depreciation and amortization	$21.1M
EBIT	$5.8M
EBITDA	$26.9M
EPS	$-0.02
FCF per share	$0.37
Financing cash flow	$-18.5M
Free cash flow	$50.4M
Free cash flow minus SBC	$43.4M
Gross profit	$677.6M
Income taxes	$949,000
Investing cash flow	$-12.3M
Net borrowing	$-16.4M
Net cash flow	$33.8M
Net income	$-2.5M
Operating cash flow minus SBC	$57.7M
Operating income	$5.8M
Revenue	$989.7M
Stock-based compensation	$7M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.32
Book value per share	$1.73
Debt / EBITDA	2.58
Debt / equity	0.32
Debt / FCF	1.73
Goodwill	$142M
Interest coverage	0.94
Long-term assets	$343.1M
Long-term liabilities	$84.7M
Net cash (debt)	$54.4M
Net cash / market cap	4.37%
Net cash growth	1,027.9%
Net debt / EBITDA	-2.02
Net debt / equity	-0.2
Net debt / FCF	-1.08
Piotroski F-Score	5
Property, plant and equipment	$187.5M
Shareholders' equity	$268.8M
Tangible book value	$90.3M
Tangible book value per share	$0.66
Total assets	$557.4M
Total cash	$141.3M
Total debt	$87M
Total liabilities	$288.6M
WACC	3.56%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.83
Current assets	$214.3M
Current liabilities	$203.9M
Current ratio	1.05
Net working capital	$-117.5M
Quick ratio	0.92
Working capital	$10.4M
Working capital turnover	91.12

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.23%
Dividend yield	0%
Shareholder yield	-0.23%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$9.47
1D price change	0.11%
1M price change	1.11%
1M total return	1.11%
1W price change	-0.55%
1W total return	-0.55%
1Y price change	81.28%
1Y return CAGR	81.35%
1Y total return	81.28%
20-day SMA	$9.10
200-day SMA	$9.03
3M price change	-20.73%
3M total return	-20.73%
3Y price change	63.67%
3Y return CAGR	17.84%
3Y total return	63.67%
50-day SMA	$9.90
50-day SMA vs 200-day SMA	50over200
52-week high	$12.64
52-week high date	2026-06-30
52-week low	$3.94
52-week low date	2025-11-05
5Y price change	44.67%
5Y return CAGR	7.67%
5Y total return	44.67%
6M price change	12.49%
6M total return	12.49%
All-time high	$27.18
All-time high date	2021-03-22
All-time low	$2.60
All-time low date	2025-04-17
Average true range (ATR)	$0.38
Average volume	587.2K
Beta (1Y)	-0.74
Beta (2Y)	0.66
Beta (5Y)	0.15
Change from 52-week high	-27.77%
Change from 52-week low	132.02%
Change from all-time high	-66.52%
Change from all-time low	250%
Change from open	-1.3%
Day's gap	1.43%
Dollar volume	$3.7M
High price	$9.35
Low price	$9.09
Monthly RSI	56.71
Open price	$9.25
Position in 52-week range	15.38%
Premarket change	-2.3%
Premarket close	$9.12
Premarket price	$8.91
Previous close	$9.12
Price vs 150-day SMA	-3.86%
Price vs 20-day SMA	0.04%
Price vs 200-day SMA	0.79%
Price vs 50-day SMA	-8.12%
Relative volume	0.69
Return from IPO open	-62%
Return from IPO price	-56.57%
RSI	42.95
Sharpe ratio	1.1
Sharpe ratio (3Y)	0.52
Sharpe ratio (5Y)	0.4
Sortino ratio	2
Sortino ratio (3Y)	0.91
Sortino ratio (5Y)	0.68
Volume	403K
Weekly RSI	48
YTD price change	75.34%
YTD total return	75.34%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	34.4M
Float percentage	25.21%
Shares change (QoQ)	1.07%
Shares change (YoY)	0.23%
Shares held by insiders	0.72%
Shares held by institutions	13.76%
Shares outstanding	136.5M
Short % of float	7.75%
Short % of shares	1.95%
Short ratio	3.6 days

Deeper analysis on INNV

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this INNV report

Is a complete INNV research report available?

No complete published report is available for InnovAge Holding Corp. (INNV) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

InnovAge Holding Corp. (INNV)

Price

Financial snapshot

Fair-value bridge

Latest news · INNV

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All INNV indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on INNV

Frequently asked questions